The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
Reasoning
The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
Cite this ruling
CBP Ruling N255003 (3004909190): The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Celexa® in dosage form, from Ireland
Request for Reconsideration of HQ H086082; Tariff Classification of Homeopathic Remedies
The tariff classification of Sildenafil (CAS-139755-83-2), imported in dosage form, from India
The tariff classification of Levetiracetam Oral Solution (CAS-102767-28-2), imported in dosage form, from India
The tariff classification of Levetiracetam (CAS-102767-28-2), imported in dosage form, from India